PREVALENCE OF SUPERFICIAL FUNGAL INFECTION IN RENAL TRANSPLANTED PATIENTS

Main Article Content

Manar Mohamed Abdelrahman Mohamed Ahmed
Dr.Nahid Ahmed Basheer
Mohammed Abderahim Hassan

Keywords

Superficial Fungal Infection, Renal Transplanted Patients, Antibiotics, Cell Mediated Immunity

Abstract

Background: Kidney transplantation is the treatment of choice for end-stage renal disease. However, patients require close follow-up after transplantation since they are on complex immunosuppressive regimens that render susceptible to infection, malignancy, and cardiovascular disease. Immunosuppressive dose also tends to be high in the first 1- 6 months post transplantation and patients continue to be at risk of developing opportunistic fungal infection.


Aim: To determine prevalence and variant of superficial fungal infection in renal transplant recipient, to determine duration of immunosuppressive drugs used before appearance of superficial fungal infection and prevalence and to find out the relationship between types of immunosuppressive drugs used and prevalence of superficial fungal infection.


Methods: This cross-sectional descriptive hospital-based study was carried out on 80 patients with renal transplant recipients attended, admitted at hospital as well as referral clinics.


Results: Sixteen Patients (20%) had superficial fungal infections at the time of the study and 64 Patients (80.0%) had no superficial fungal infection. Regarding dermatological examination Skin involved in 13 Patients (16.2%), mucous membrane involved in1 Patients (1.2%), nail Involved in1 Patient (1.2%), Finger toe involved in1 Patients (1.2%).


Conclusions: Pityriasis versicolor was the commonest superficial fungal infection in renal transplant recipients. Superficial fungal infection was more common in first 6months of treatment of immunosuppressive drugs and was more common in patient used combination of Azathioprine + predinsolone +prograf.

Abstract 92 | Pdf Downloads 35

References

1. Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 1999;12:501-17.
2. Howell SA. Dermatopathology and the diagnosis of fungal infections. Br J Biomed Sci. 2023;80:11314.
3. Björnsdóttir S, Gottfredsson M, Thórisdóttir AS, Gunnarsson GB, Ríkardsdóttir H, Kristjánsson M, et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis. 2005;41:1416-22.
4. Bryant AE, Bayer CR, Chen RY, Guth PH, Wallace RJ, Stevens DL. Vascular dysfunction and ischemic destruction of tissue in streptococcus pyogenes infection: The role of streptolysin o-induced platelet/neutrophil complexes. J Infect Dis. 2005;192:1014-22.
5. Bradley SF. Staphylococcus aureus infections and antibiotic resistance in older adults. Clin Infect Dis. 2002;34:211-6.
6. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol. 1998;39:383-98; quiz 99-400.
7. Rosen T, Schell BJ, Orengo I. Anti-inflammatory activity of antifungal preparations. Int J Dermatol. 1997;36:788-92.
8. Sardana K, Gupta A, Mathachan SR. Immunopathogenesis of dermatophytoses and factors leading to recalcitrant infections. Indian Dermatol Online J. 2021;12:389-99.
9. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med. 1994;331:365-76.
10. Lally A, Casabonne D, Imko-Walczuk B, Newton R, Wojnarowska F. Prevalence of benign cutaneous disease among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol. 2011;25:462-70.
11. Güleç AT, Demirbilek M, Seçkin D, Can F, Saray Y, Sarifakioglu E, et al. Superficial fungal infections in 102 renal transplant recipients: a case-control study. J Am Acad Dermatol. 2003;49:187-92.
12. Imko-Walczuk B, Prędota A, Okuniewska A, Jaśkiewicz J, Zegarska B, Placek W, et al., editors. Superficial fungal infections in renal transplant recipients. Transplantation Proceedings; 2014: Elsevier.

Most read articles by the same author(s)